marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 04-08-2024
Eiger BioPharmaceuticals ROE Ratio 2011-2024 | EIGR
Annual ROE Ratio Eiger BioPharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 518.49 | -174.97 | -46.85 | -68.45 | -124.38 | -78.67 | -188.47 | -115.63 | -140.76 | -46.95 | -219.56 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 518.49 | -219.56 | -62.38 |
Quarterly ROE Ratio Eiger BioPharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 889.48 | -269.2 | -155.16 | -79.16 | -104.0 | -94.22 | -90.53 | -19.23 | -35.73 | -27.39 | -25.95 | -48.66 | -81.62 | -98.08 | -112.99 | -94.43 | -120.17 | -112.96 | -96.81 | -53.9 | -94.61 | -109.58 | -144.18 | -140.11 | -168.03 | -155.24 | -138.16 | -84.28 | 7.84 | 159.91 | 513.08 | 552.62 | -1675.28 | -1811.02 | -2141.46 | -2167.0 | -5915.98 | -5893.7 | -5874.4 | -5857.67 | 27.09 | 16.4 | 6.8 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 889.48 | -5915.98 | -742.27 |